You are here: Industry Insights > AmerisourceBergen

News List

New York, drug distributors reach $1.18 billion opioid settlement as national deal looms expresspharma
July 22, 2021
The three largest US drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nation-wide opioid epidemic, the state’s attorney general said 20th.
Parexel Said to Draw Interest From AmerisourceBergen, PE Firms firstwordpharma
June 25, 2021
According to people familiar with the matter, pharmaceutical services company Parexel has drawn interest from suitors including AmerisourceBergen, Bloomberg reported.
AmerisourceBergen Acquires Alliance Healthcare Businesses americanpharmaceuticalreview
June 04, 2021
AmerisourceBergen Corporation announced the completion of its acquisition of the majority of Walgreens Boots Alliance’s Alliance Healthcare businesses for $6.275 billion in cash, subject to a customary working capital and net debt adjustment ...
Pharma is making steady progress toward meeting 2023 DSCSA requirements, finds study europeanpharmaceuticalreview
March 16, 2021
Over 90 percent of packages at three companies met all of the Drug Supply Chain Security Act (DSCSA) labelling requirements in 2020, despite there being three years until the final deadline.
AmerisourceBergen Coughs Up $625M to Resolve U.S. Government Probe biospace
November 24, 2017
A unit of AmerisourceBergen Corporation, one of the largest U.S. drug wholesalers, has agreed to pay $625 million to resolve a U.S. government probe involving pre-filled syringes, the company said in a filing with U.S. securities regulators on Tuesday.
AmerisourceBergen says civil penalty to resolve DOJ probe now at $625M fiercepharma
November 23, 2017
It turns out that the quarter-crushing $575 million that drug wholesaler AmerisourceBergen set aside to settle civil litigation with the Justice Department was not enough. It is going to take another $50 million.
AmerisourceBergen sees end in sight for industrywide generics woes fiercepharma
November 06, 2017
Generic drug prices have continued their downward spiral thanks to pressure from consolidated purchasers. But one distributor sees light at the end of the tunnel.
AmerisourceBergen agrees to $13.4M settlement in Novartis kickback case fiercepharma
August 24, 2017
The specialty pharmacy unit of AmerisourceBergen has agreed to pay more than $13 million to resolve allegations that it got kickbacks to push a drug for Novartis.